02/18/2026
We are so excited to continue to be one of the top-ranked pediatric departments nationally in NIH funding. This achievement is so much more than a ranking. It reflects the hard work, perseverance, and passion our researchers have for advancing child health. Check out some highlights from the past year ➡️https://www.choa.org/-/media/Files/Childrens/research/2025-research-report.pdf
We’re excited to announce that Children’s and Emory University School of Medicine are celebrating four years in the top 3 and a decade in the top five for National Institutes of Health (NIH) research funding awarded to pediatrics departments. Notable projects supporting this ranking and physician training highlights are now available in the 2025 Research and Education Report: Championing Pediatric Science and Training. The funding allows researchers to work toward groundbreaking cures, treatments and innovations such as leading a national trial to improve survival in extremely preterm babies. View the report: https://www.choa.org/-/media/Files/Childrens/research/research-and-education-report_2025.pdf.
02/05/2026
📢 Registration is now open for the 2026 Southeastern Pediatric Research Conference, featuring groundbreaking child health research from throughout the region and beyond!
⚕️2026 theme: “Bench to Bedside and Beyond: Risk Factors and Intervention Strategies in Childhood Disease and Injury”
🗓️ August 28, 2026
📍 Georgia Aquarium
✅ Register here: https://bit.ly/4tiX9Ee
10/28/2025
Earlier this month, the first Marcus Center for Cellular Therapy patient was infused with cell therapy.
Born with dilated cardiomyopathy, a condition in which the heart becomes enlarged and cannot pump blood effectively, Gabrielle has undergone several procedures and spent many years in and out of our hospital for treatment. When she learned about a new study exploring how newborn donor stem cells could be used to combat dilated cardiomyopathy, Gabrielle was eager to participate. She saw this opportunity as a chance to make a difference and help future patients facing the same condition.
On October 7, under the care of Dr. Michael Davis, Director of the Emory and Children's Heart Research and Outcomes Center, Dr. William Mahle, Chief of Cardiology and Co-Chief of the Children’s Heart Center and Dr. Edwin Horwitz, Director of the Transplantation Biology and Therapeutics at our Aflac Cancer & Blood Disorders Center, she received the first of three infusions, with her next two scheduled before the end of this year. She is one of 24 patients who will participate in the two-year trial.
